|
|
||||||||
1 Department of Anesthesiology, Oregon Health Sciences University and Veterans Affairs Medical Center, Portland, Oregon 97201; and 2 United States Department of Agriculture/Agricultural Research Services Children's Nutrition Research Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas 77030
It has been
suggested that hepatic urea synthesis, which consumes
HCO
3, plays an important role in
acid-base homeostasis. This study measured urea synthesis rate
(Ra urea) directly to assess its
role in determining the acid-base status in patients with end-stage
cirrhosis and after orthotopic liver transplantation (OLT). Cirrhotic
patients were studied before surgery
(n = 7) and on the second
postoperative day (n = 11), using a
5-h primed-constant infusion of
[15N2]urea.
Six healthy volunteers served as controls.
Ra urea was 5.05 ± 0.40 (SE)
and 3.11 ± 0.51 µmol · kg
1 · min
1,
respectively, in controls and patients with cirrhosis (P < 0.05). Arterial base excess was 0.6 ± 0.3 meq/l in controls and
1.1 ± 1.3 meq/l in cirrhotic patients (not
different). After OLT, Ra urea was 15.05 ± 1.73 µmol · kg
1 · min
1,
which accompanied an arterial base excess of 7.0 ± 0.3 meq/l (P < 0.001). We conclude that
impaired Ra urea in cirrhotic
patients does not produce metabolic alkalosis. Concurrent postoperative metabolic alkalosis and increased
Ra urea indicate that the
alkalosis is not caused by impaired
Ra urea. It is consistent with,
but does not prove, the concept that the graft liver responds to
metabolic alkalosis by augmenting
Ra urea, thus increasing
HCO
3 consumption and moderating the
severity of metabolic alkalosis produced elsewhere.
cirrhosis; acid-base metabolism; base excess; metabolic alkalosis; ammonia
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |